Bailey Fisher Executive Search is pleased to have assisted Sorex Sensors with the search for a CEO, resulting in the appointment of electronics pioneer Michael LeGoff. The search was managed by John Bridger, Director – Technology Practice.
Cambridge University spin-out Sorex Sensors has appointed Michael LeGoff, the former founder and CEO of the relaunched electronics pioneer Plessey Semiconductors. He has more than 25 years of industry experience focused on commercialising technology and has been the catalyst for innovation and growth in a number of technology companies. He takes up his new appointment with immediate effect.
Former Sorex Sensors CEO John Pritchard will continue to support the business in an advisory role until mid-April.
The sensor technology company raised £1.2 million seed funding last year from Cambridge Enterprise, the Cambridge Angels and Cambridge Capital Group.
LeGoff said: “Sorex Sensors is poised to transform a whole range of industries with its innovative sensor technology. The team has done a fantastic job in bringing its novel sensing technology close to the product launch stage. We are now focusing on a few key industrial applications where the technology will have an immediate and tangible impact, creating real demand. It’s great to be involved in a business where the path to scale production is relatively clear.”
Sorex Sensors has developed a novel mass sensor based on film bulk acoustic resonator (FBAR) technology. The new sensor is extremely small – as thin as a human hair – and can be arranged into arrays on the same chip to measure different targets simultaneously. It has high mass sensitivity, down to one femtogram – the weight of the average virus particle.
Initial applications include monitoring vehicle emissions; measuring industrial air quality; the detection of various biomolecular structures in the body; and improving the performance and accuracy of atomic layer deposition tools, which is a key part of the fabrication of semiconductor devices. The sensor can be operated from a coin cell battery, a mobile phone or even from energy harvesting devices.
Professor Andrew Flewitt, co-founder and chairman of Sorex Sensors, said: “We are delighted to have Michael join the team. We are looking forward to this next phase of development, both in terms of products and commercial traction in our early-stage business. John Pritchard has been hugely influential in getting us to this stage, including putting together the seed round and developing the early-stage strategy for the company. Michael and the team have a great platform to build on.”
Bailey Fisher Executive Search is pleased to have assisted Endomag with the search for a Clinical Development Director, a new position created to lead the company’s clinical activities during a period of rapid growth.
Endomag is a venture backed medical devices business, providing a better standard of cancer care for patients around the globe. The incidence of cancer is growing, and with it the demand for better, faster and less expensive solutions for diagnosis and treatment. With the aim of bringing cancer care to everyone, everywhere, Endomag is developing a clinical platform that uses safe magnetic fields to power diagnostic and therapeutic devices, avoiding the safety, workflow and availability concerns of ionizing radiation. Endomag was founded in 2007 as a spin-out from University College London and the University of Houston, and is backed by investors including Draper Esprit. The company has won a number of awards including an Innovate UK SME Innovation Award, was a finalist for the prestigious MacRobert Award from the Royal Academy of Engineering (2015), and more recently was awarded a Queen’s Award for Enterprise Innovation.
The Clinical Development Director search was managed by Iain Hopper, Director of Health Technology & Life Sciences at Bailey Fisher. The search resulted in the appointment of Matthew Womack, who brings extensive experience within both early stage growth business and big pharma.
Bailey Fisher Executive Search is pleased to have assisted Darktrace on the search for an FD, resulting in the appointment of Rachel Elias-Jones.
Modeled on the human immune system, Darktrace’s technology is the world’s leading, enterprise-grade AI with over 7,000 deployments worldwide.
The company was founded in Cambridge, UK, in 2013 by mathematicians and machine learning specialists from the University of Cambridge, together with world-leading intelligence experts from MI5 and GCHQ, to bring transformative technology to the challenge of cyber security.
Darktrace has experienced rapid growth since its foundation, growing revenues by over 600% year-over-year, and recruiting over 500 employees working across 24 global offices. The company is now valued at $1.25bn and is headquartered in Cambridge, UK and San Francisco, with global offices in New York, Auckland, London, Milan, Mumbai, Paris, Seoul, Singapore, Sydney, Tokyo, Toronto and Washington D.C.
Bailey Fisher was engaged to manage the search for this key operational appointment. The search was led by Andrew Moore, Managing Director of Bailey Fisher.
Bailey Fisher is pleased to have assisted Undo, a pioneer in the development of new software execution record and replay technology, with the appointment of Barry Morris as its new CEO with immediate effect.
Barry will take over the role from co-founder Dr Greg Law, who has to date been performing a dual CEO/CTO role. Greg will now dedicate his time and focus to operating as Undo’s CTO, developing Undo’s technical capabilities in line with evolving customer demand.
Barry has swapped one Cambridge for another, moving from Cambridge, Massachusetts based NuoDB, to operate out of Undo’s Cambridge UK headquarters. A serial entrepreneur, Morris founded NuoDB in 2008 and most recently served as its Executive Chairman.
With over 25 years’ experience working in enterprise software and database systems, he is a prodigious company builder, scaling start-ups and publicly held companies alike. Morris, who was CEO of distributed service-oriented architecture (SOA) specialists IONA Technologies between 2000 and 2003, built the company up to $180m in revenues and a $2bn valuation.
Greg Law commented, “We have achieved our early stage goals. With the industry-changing technology we have built, the customers we have signed up and the funding we have secured, it is time to move to the next stage of the plan, with an A-player to lead the company in its high-growth phase.
“Despite a really strong short list of candidates, the result of a worldwide executive search, we were unanimous in our agreement about who the right person to lead the company should be, and that’s Barry.”
Barry Morris added, “Greg and the team at Undo have built incredible foundations for the company, with technology that was thought by many to be an impossibility, and an enviable customer list including IBM, SAP and Micro Focus. My focus will be on the next evolution of the company, as we strengthen our positioning in strategically important markets like the US and Europe.”
“There is a substantial opportunity for Undo right now. All businesses are becoming highly dependent on software reliability, and Undo uniquely delivers reliability solutions across the software lifecycle. The industry wave of investment in continuous integration and deployment (CI/CD) is part of a drive for software quality, but the absence of a modern software reliability platform remains a pervasive challenge in these environments. Undo is perfectly and uniquely positioned to address this challenge.”
Undo has grown rapidly in recent years, growing headcount to 40, with a world-class engineering team in Cambridge and an experienced enterprise sales organisation in San Francisco. In July, the company announced that it had secured $14 million in series B funding, and has to date, raised over $20 million in venture funding from leading venture capitalists.
Greg Law concluded, “We reached the size and complexity where it was impossible for one person to be both CEO and CTO. It’s a fantastic coup for the company to bring in someone with Barry’s international experience of putting innovative companies firmly on the map, raising finances, and building sustainable revenue streams.”
Bailey Fisher is pleased to have assisted SatSense, a spin-out from the University of Leeds, with the search for a CEO, resulting in the appointment of David Blain.
SatSense makes innovative use of satellite data to map ground deformation for use in what is potentially a huge global market. The SatSense technology can precisely measure changes in ground movement to as little as 1mm per year and represents a step change in resolution and accuracy over anything that is currently in the market.
Following investment from NPIF – Mercia Equity Finance which is part of the Northern Powerhouse Investment Fund, Unipart Rail and the University of Leeds, Bailey Fisher was engaged to search for a CEO to work with the founders to develop the commercial position of the company. The search was led by John Bridger, Technology Director at Bailey Fisher.
The search resulted in the appointment of David Blain, a commercial leader with strong software sales experience within SatSense’s target client-base.
Bailey Fisher Executive Search is pleased to have assisted Sitec Infrastructure Services with the search for a CFO, resulting in the appointment of Aaron Kelly.
Sitec Infrastructure Services is a multidisciplinary national firm operating in the telecommunications and energy sectors. They work with some of largest network operators and their deployment partners providing a diverse range of surveying, design and management services covering all areas of their transmission networks from microcell management to upgrades and 4G rollout.
Bailey Fisher was engaged to manage the search for a CFO to serve as a key member of the management team at an exciting stage in the company’s development. The successful candidate, Aaron Kelly, was previously Group FD at Aspall Cyder and Finance Director for Greene King.
Bailey Fisher Executive Search is pleased to have assisted Congenica with the search for a CFO, resulting in the appointment of Wendy Britten.
Congenica, the global provider of clinical genomics interpretation software, has announced the appointment of Wendy Britten as its new Chief Financial Officer, effective 1st September, 2018.
Wendy will have overall control and responsibility for all financial aspects of the business and will play a key role in business development and fundraising activities.
A finance professional with experience in senior financial leadership roles, Wendy joins Congenica from AstraZeneca, where she headed up the Group Finance Business Performance team, working with the Senior Executive team. Prior to this, her career at PricewaterhouseCoopers (PwC) started in Audit, progressing ultimately to Director of M&A in both London and New York. She is a qualified Chartered Accountant and holds a BSc in Mathematics from the University of Sheffield.
David Atkins, CEO of Congenica, said:
“I am delighted to welcome Wendy to Congenica. She joins our Senior Management team at a pivotal time in the Company’s development. She brings financial leadership and business development expertise, as we move forward commercially on the back of our successful series B financing last year. Her international experience will support our operational expansion in the UK and across Europe, China and the US.”
Dr Andy Richards, Chairman of Congenica, said:
“Mrs Britten’s ambitious and energetic outlook and considerable experience adds to our skills as Congenica continues its successful trajectory in the international genomics sector. Her appointment underlines our ambition to become a significant global player, providing a critical service that enables genomics to deliver on its promise in human healthcare.”
Led by CEO David Atkins the past year has seen significant advancements for Congenica, including a successful Series B funding round that raised USD $13.5M from leading China- and UK-based investors. Congenica’s gold-standard Sapientia™ clinical genomic analysis platform is currently routinely used by hundreds of clinicians as well as supporting several major projects globally – including Genomics England’s ground-breaking 100K Genomes Project and China’s national 100K wellness project.
Commenting on her appointment, Congenica’s new CFO Wendy Britten said:
“I am looking forward to the opportunities that joining the team at Congenica offers. With a strong commitment to positively impacting patient’s lives, Congenica is poised for substantial growth. The field of genomic medicine has the potential to revolutionise our approach to rare genetic disease diagnosis and management, as well as in other areas of personalised medicine.”
Bailey Fisher Executive Search is pleased to have worked with Sense Biodetection on the search for a Chairman, resulting in the appointment of Heiner Dreismann.
Sense Biodetection Limited (Sense) is an early stage, venture backed molecular diagnostics business, based in Oxford and Cambridge. Following an international search, Bailey Fisher sourced Heiner Dreismann, a leading light in molecular diagnostics, with 35 years’ experience leading high-growth businesses on a global basis. Heiner was previously President and CEO of Roche Molecular Systems, the world leader in molecular diagnostics.
During his tenure at Roche Molecular Systems, Heiner oversaw the substantial growth of the PCR business, with revenues doubling in five years. In his earlier career at Roche, Heiner led the integration office of the successful acquisition of Boehringer Mannheim into Roche Diagnostics, and went on to become Head of Global Business Development with responsibility for the entire diagnostics business.
Commenting on his appointment, Heiner said: “I am delighted to join Sense at this exciting stage in its development and to be in a position to help the company achieve its ambitious plans. Sense has a compelling proposition and a significant opportunity to transform the IVD field with a new class of molecular diagnostic product.”
Bailey Fisher Executive Search is pleased to have assisted Fourex, the World Money Exchange Self-Service solution, with the search for a CEO, resulting in the appointment of Anthony Rice.
Fourex serves customers across the UK at automated locations by providing currency exchange for 150 currencies in banknotes and coins, including domestic cash. Offering a first to the global market, Fourex is set to revolutionise the way in which consumers exchange money. Fourex kiosks are able to accept unsorted coins and notes, that are both in and out of circulation, from over 150 currencies at the same time, and pay out in either GBP, Euros or American Dollars in a fraction of a second.
The CEO search for Fourex was led by John Bridger, Technology Associate at Bailey Fisher, and resulted in the successful appointment of Anthony Rice. Anthony has extensive global experience within dynamic currency conversion, including global leadership roles within Travelex based in both the UK and US.
Bailey Fisher Executive Search is pleased to have assisted Carbon Air with the search for a CEO, resulting in the appointment of Erwin Wolf.
Carbon Air is a growing, venture backed business based in Manchester. The company was spun out of the University of Salford in 2011 and specialises in research and development in acoustic materials, noise control, audio and air suspension.
Bailey Fisher was engaged to manage the search for a high-performing, commercially-minded CEO to bring the product portfolio to market and drive the company at an exciting stage of development.
The search resulted in the successful appointment of Erwin Wolf, an experienced business leader with a background driving growth within an international environment.